Andros Pharmaceuticals Co.,Ltd (6917.TWO)

TWD 17.6

(-3.3%)

Annual Cash Flows

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Operating Cash Flow -46.64 Million -35.75 Million -35.87 Million -26.74 Million -
Net Income -68.13 Million -41.17 Million -37.1 Million -35.85 Million -
Depreciation & Amortization 6.19 Million 6.36 Million 6.87 Million 7.45 Million -
Deferred income taxes - - - - -
Stock-based compensation 3000.00 - - - -
Change in working capital 15.42 Million -768 Thousand -5.63 Million 1.68 Million -
Other non-cash items -3.93 Million -868 Thousand 89 Thousand -443 Thousand -
Investing Cash Flow -27.33 Million -137.79 Million 25.89 Million 23 Million -
Investments in PPE -582 Thousand -46 Thousand - -2.09 Million -1.15 Million
Acquisitions - - - - -
Investment purchases -287.6 Million -193.69 Million -53.04 Million -78.94 Million -
Sales/Maturities of investments 260.85 Million 55.94 Million 78.94 Million 104.09 Million -
Other Investing Activities - - - -50 Thousand -104 Thousand
Financing Cash Flow 255.01 Million 247.11 Million 9.22 Million -4.56 Million -
Debt repayment - - - - -
Dividends payments - - - - -
Common Stock Repurchased - - - - -
Common Stock Issuance 260 Million 252 Million 13.85 Million - -
Other Financing Activities -4.98 Million - - - -
Accounts receivables 6.37 Million - - - -
Accounts payables - - - - -
Inventory -5000.00 -26 Thousand -185 Thousand -263 Thousand -
Other working capital 9.05 Million - - - -
Cash at beginning of period 88.19 Million 14.63 Million 13.79 Million 22.76 Million -
Cash at end of period 269.01 Million 88.19 Million 14.63 Million 13.79 Million -
Capital Expenditure -582 Thousand -46 Thousand - -2.09 Million -1.15 Million
Effect of forex changes on cash -219 Thousand -4000.00 1.58 Million -649 Thousand -
Net cash flow / Change in cash 180.82 Million 73.55 Million 837 Thousand -8.96 Million -
Free Cash Flow -47.22 Million -35.8 Million -35.87 Million -28.84 Million -1.15 Million

Cash Flow Charts